https://verygoodnewsisrael.blogspot.com/
ISRAEL’S MEDICAL ACHIEVEMENTS
Rolling out the vaccine. 140,000 Israelis were vaccinated in the first three days of the Pfizer vaccine rollout. (This editor received his first dose of vaccine on the sixth day). In addition, Magen David Adom are deploying unique mobile vaccination caravans, made by Israel’s Caravila.
https://unitedwithisrael.org/israel-fastest-country-in-the-world-vaccinating-its-population-against-covid-19/
https://worldisraelnews.com/israel-prepares-vehicles-for-mobile-covid-and-flu-shots/
Fat treatment proved to kill Covid-19. Hebrew University scientists have completed a study of 1500 Covid-19 patients receiving anti-cholesterol treatments. The study showed fast recovery and no deaths. Now a full clinical trial is to commence on the fat-busting treatment Fenofibrate (Tricor) (reported here previously).
https://campaign.huji.ac.il/news/could-fibrates-turn-effects-corona-little-more-common-cold
Microbiota shrinks melanoma tumors. A small Phase 1 trial of 10 terminally ill melanoma patients at Israel’s Sheba Medical Center resulted in the lives of two patients being extended and one cured completely. Doctors transplanted fecal material from the gut microbiome of previously cured melanoma patients.
https://www.timesofisrael.com/fecal-transplants-may-help-flush-tumors-from-body-israeli-doctors-find/
https://science.sciencemag.org/content/early/2020/12/09/science.abb5920
New approach to Dry Eye Disease. (TY Atid-EDI) Israel’s Azura Ophthalmics is tackling Dry Eye Disease (DED) by preventing its root cause – Dysfunction of the Meibomian Gland or MGD. Azura has reported good results during the Phase 2 clinical trials of its AZR-MD-001 ointment, applied to the lower eyelid.
https://en.globes.co.il/en/article-dry-eye-treatment-co-azura-ophthalmics-raises-20m-1001346802
https://finance.yahoo.com/news/azura-ophthalmics-announces-primary-endpoints-130000591.html
https://azuraophthalmics.com/ https://www.youtube.com/watch?v=Xfjkv7Qxymc
Blood test detects early-stage lung cancer. (TY Atid-EDI) In tests, the Lung EpiCheck blood test developed by Israel’s Nucleix (reported here previously) detected 85% of early stage lung cancers among smokers and ex-smokers with a high risk for developing the disease. On low-risk individuals, the accuracy increased to 91%.
https://nucleix.com/news_and_events/nucleixs-lung-epicheck-liquid-biopsy-test-detects-85-of-early-stage-lung-cancers-in-high-risk-smokers-study-published-in-european-respiratory-journal/
The sight of blood. (TY Atid-EDI) Israel’s Scopio Labs (reported here previously) has added software to its next generation of high-powered microscopes. It uses AI to scan, digitize and analyze blood for hematological diagnosis. Scopio has just received FDA clearance for its Full Field Peripheral Blood Smear Application.
https://www.prnewswire.com/news-releases/scopio-labs-receives-fda-clearance-for-its-ai-powered-full-field-peripheral-blood-smear-full-field-pbs-application-301156907.html https://scopiolabs.com/
https://www.youtube.com/watch?v=gOdglVTX150
Senior’s cancer prize. Israel’s Nutek has won the Merage 45+ Entrepreneurs’ Competition. Founder and Exec Chairman, Dov Cohen received the $100,000 prize, which rewards Israeli entrepreneurs aged 45 and over. Cohen’s Nutek has developed probes that locate cancer cells remaining in a patient during tumor removal.
https://www.israelhayom.com/2020/12/22/startups-not-only-for-gen-z/ https://nutekmedtech.com/
Interfaith charity donates medical kits and more. The International Fellowship of Christians and Jews (IFCJ) recently donated 160 emergency medical kits for the volunteer medics of Israeli NGO United Hatzalah. The IFCJ also donated personal protection equipment and communication devices, for use by first responders.
https://www.jpost.com/israel-news/interfaith-organization-provides-medical-kits-to-israeli-volunteers-652865
Donation to complete blood center. The Marcus Foundation is donating $10 million to ensure completion of Israel’s new MDA shielded national blood services center at Ramla (reported here previously), that will protect Israel’s strategic blood reserves against missile, chemical, and biological attack.
https://www.israelnationalnews.com/News/News.aspx/293532